解锁脂质II:获得主要抗生素标的策略
Luke J Tyrie1, Milandip Karak1, Stephen A Cochrane1
1School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir Building, Stranmillis Road, Belfast, BT9 5AG, UK. m.karak@qub.ac.uk.
概括
抗菌素耐药性 (AMR) 是一个日益增长的威胁. 本综述探讨了获得主要细菌点脂质II的方法,以帮助开发新抗生素和了解细菌过程.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 抗菌素耐药性 (AMR) 构成了重大的全球卫生危机,预计死亡率将增加.
- 了解抗生素-标相互作用对于合理的药物设计来打击AMR至关重要.
- 脂质II是细菌细胞壁生物合成的重要前体,是新型抗生素的关键目标,但其可获得性具有挑战性.
研究的目的:
- 审查和比较获得脂质II的主要策略,一种重要的细菌细胞壁前体.
- 评估每个脂质II获取方法的优点,局限性,可扩展性和结构控制.
- 突出改善脂质II可访问性的进展,用于抗生素研究和了解细菌生理学.
主要方法:
- 从细菌来源直接提取脂质II.
- 使用生物合成机器的脂质II的酶或化学酶组合.
- 脂质II及其类型的总化学合成.
主要成果:
- 每种方法在产量,纯度和可扩展性方面都有明显的优点和缺点.
- 酶和化学合成方法可以更好地控制脂质II结构.
- 最近的创新正在提高脂质II和相关化合物的可访问性.
结论:
- 获取脂质II的改进方法对于推动抗生素的发现和开发至关重要.
- 提高脂质II的可访问性可以更深入地了解细菌细胞壁生物合成和生理学.
- 这些策略对于开发新疗法来应对抗微生物药物耐药性日益增加的威胁至关重要.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Bioavailability Enhancement: Drug Permeability Enhancement
163
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
163
Biosynthesis of Lipids
479
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
479
Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
Formation of Lipopolysaccharides
481
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
481
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K


